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While increased resistance to portal blood flow is a central feature of portal
hypertension, the varied clinical presentations ofthis syndrome and their relation to
the underlying divergent splanchnic hemodynamic patterns remain puzzling. Some
patients present with massive ascites, repeated hemorrhage from ruptured esopha-
geal varcies, and severe hypersplenism, whereas others with equivalent or even
higher portal pressure readings are symptom-free. Nonetheless, each of these
serious complications is generally conceded to be somehow a direct consequence of
high portal pressure. Portal pressure, however, depends not only upon resistance to
portal flow through the liver and through portasystemic collaterals bypassing the
liver, but also upon the volume of splanchnic blood feeding into the portal system
from the gastrointestinal tract, pancreas, and spleen. Thus, at any given moment,
the level ofportal pressure is the resultant ofa whole set ofrapidly changing interre-
lated flows and vascular resistances in the splenic, mesenteric, hepatic, and systemic
circulations (1).
Less than 30 yr ago, the "syndrome" of pulmonary hypertension appeared
equally perplexing. Pulmonary artery pressure likewise depends upon a complex set
of rapidly changing interrelated flows and vascular resistances albeit in the systemic
and pulmonary circulations. But then the cardiac catheter was introduced into the
heart and great vessels, and blood flow and vascular pressure measurements were
made at key points in these two circulations. Today, a variety of forms of
pulmonary hypertension are recognized which have their own distinctive clinical
presentations and are defined by specific hemodynamic criteria (2). Unfortunately,
the events in portal hypertension take place in the relatively inaccessible splanchnic
bed, and methodology continues to be a major stumbling block in obtaining com-
pletehemodynamic data. Direct measurement ofindividual organ blood flowusually
must be made under artificial or less than ideal conditions (e.g., at laparotomy), and
indirect quantitation ofportasystemic shunted flowis at best a rough approximation
(3). Thus, "catheterization data" (simultaneous measurements offlow and pressure)
at key points in the splanchnic circuit (splenic, mesenteric, hepatic, and portal) in
patients with portal hypertension comparable to "catheterization data" in patients
with pulmonary hypertension are simply not available.
The influence ofsplanchnic blood flow on portal dynamics is well illustrated in ex-
perimental right-sided congestive heart failure in thedog. Banding ofthe pulmonary
artery alone or in combination with disruption of the tricuspid valve regularly
produces marked systemic venous hypertension, massive hepatomegaly, engorge-
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ment of hepatic hilar lymphatics, and weeping of ascitic fluid from the liver. The
spleen, however, is shrunken (Fig. 1), and lymphatics draining the extrahepatic
portal bed are not prominent (4). In this model, blood flow into the splanchnic
viscera decreases in response to the over-all reduction in cardiac output, peripheral
resistance rises, and arteriovenous oxygen extraction widens (passive congestion)
(5-7). Thus, despite increased resistance to the return ofblood via thegreatveins, si-
multaneous reduction in flow into the splanchnic bed minimizes or negates any rise
in portal pressure and modifies the intensity and severity ofcongestion in the diges-
tive tract and spleen.
In striking contrast to the dog with right-heart failure is the patient with portal
hypertension from hepatic cirrhosis. In this disease (but not in portal hypertension
from isolated portal vein occlusion) peripheral pulses are often bounding, cardiac
output increased, systemic vascular resistance low (8, 9), and arteriovenous oxygen
extraction narrow (10). Moreover, splenomegaly is prominent and occasionally
massive, splanchnic arteries particularly to the spleen may be enlarged (11, 12),
mesenteric and splenic lymphatics are widely dilated, and peritoneal surfaces ofthe
bowel and mesentery are the predominant source ofascitic fluid (13). Furthermore,
after reduction in splanchnic arterial flow through selective infusion of pitressin (a
potent splanchnic vasoconstrictor) into the superior mesenteric and splenic arteries,
portal pressure falls acutely and esophageal varix hemorrhage temporarily ceases
(14). Thus, whereas increased resistance to portal flow is present in both right-heart
failure (transmitted back from the central veins) and hepatic cirrhosis (transmitted
back from the scarred regenerating liver), only in cirrhosis where splanchnic blood
flow is maintained does portal hypertension and extrahepatic portal congestion de-
velop.
The differing effects of stagnant as opposed to hyperdynamic blood flow in the
FIG. 1. Massive hepatomegaly (680 g) and splenic atrophy (15 g) in dog 4 wk after banding of the
main pulmonary artery with an ameroid constrictor (casein hydrolysate). Gradual swelling of the
constrictor (hydrophilic) promoted progressive right-sided heart failure with systemic venous h-yperten-
sion and massive ascites. Despite prominent engorgement of the liver, congestion of the extrahepatic
portal bed was minimal.
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pathophysiology of portal hypertension are seen in experiments carried out acutely
in dogs. After marked constriction of the portal vein (to approximately 25-50% of
the original diameter), portal pressure rises sharply and concomitantly lymph
formation in the extrahepatic portal bed increases, mesenteric vascular resistance
rises, arterial inflow decreases, and arteriovenous oxygen extraction across the gut
widens as oxygen delivery falls (the pattern of "passive congestion") (Fig. 2). On the
other hand, doubling or even tripling mesenteric blood flow by intravenous infusion
of glucagon does not produce significant portal hypertension (Fig. 3). When,
however, intravenous infusion of glucagon is combined with only minimal constric-
tion of the portal vein (to approximately 80-90% of the original diameter), portal
pressure and extrahepatic lymph production increase sharply, but the entire physio-
logic pattern differs from that induced by portal vein constriction alone. Specifically,
mesenteric blood flow and oxygen delivery to the gut are preserved, and mesenteric
venous blood is highly saturated with oxygen ("active congestion") (Fig. 4). Al-
though these experiments confirm the necessity of some degree ofincreased portal
vascular resistance in the production ofportal hypertension, they also demonstrate
that forced maintenance of "forward flow" in the splanchnic bed in the face of in-
creased portal vascular resistance reproduces more closely the findings of portal
hypertension in hepatic cirrhosis.
Splenomegaly, a common feature in portal hypertension, also provides a clue to
the role of arterial flow in the genesis ofportal hypertension. Although the enlarged
spleen is usually viewed as the end result of transmission of high portal venous
pressure backward into the spleen ("passive congestion") (16) the degree of
splenomegaly correlates poorly with the level of portal pressure (17, 18) or the
severity and duration ofportal or splenic venous obstruction (19, 20). Moreover, the
spleen may be greatly enlarged and congested in the absence ofportal hypertension
(21), splenic venous blood in patients with portal hypertension is typically highly
saturated with oxygen (10) (in contrast to "passivecongestion"), reduction ofportal
pressure by portasystemic shunt often does not appreciably reduce splenic size (18)
and neither sustained congestive splenomegaly nor persistent elevation in splenic
venous pressure follows chronic obstruction to splenic venous flow in experimental
animals (10, 22, 23). Splenic size does correlate, however, with the magnitude of
splenic arterial flow which may be three to five times normal in patients with
massive splenomegaly (Fig. 5). Yet abrupt interruption of splenic inflow (e.g., by li-
gation of the splenic artery) rarely lowers pressure to normal and sometimes barely
affects it at all (21, 24) suggesting that other hemodynamic variables (e.g.,
mesenteric blood flow and portal vascular resistance) curiously adjust to sustain the
elevation in portal pressure (25). Nonetheless, occasionally splenectomy or splenic
artery ligation with preservation of splenic venous collaterals suffices to control
esophageal varix hemorrhage or ascites (vide infra).
In diseases placing a sustained excess "work load" on the reticuloendothelial
system (e.g., production ofabnormal erythrocytes in hereditary spherocytosis or ac-
cumulation of macromolecular cerebrosides in Gaucher's disease), splenic enlarge-
ment and increased splenic blood flow accompanies reticuloendothelial proliferation
(21, 26, 27). Similarly, in primary disorders of the reticuloendothelial system and
blood-forming organs (e.g., myeloid metaplasia or the dysproteinemias), the spleen
participates in the pathologic process, and splenomegaly with hyperdynamic splenic
blood flow is often observed (26, 28, 29). In portal hypertension, too, the enlarged
spleen demonstrates prominant white pulp hyperplasia in addition to red pulp
congestion (20). This reticuloendothelial response is likely related to reduction in
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FIG. 2. Circulatory dynamics in the extrahepatic portal bed of the dog after induction of portal
hypertension by narrowing of the portal vein. Note the sharp fall in superior mesenteric arterial (SMA)
flow and rise in mesenteric vascular resistance accompanied by progressive decline in oxygen saturation
(HbO2) of mesenteric venous blood and widened arterial-mesenteric venous (A-MV) oxygen extraction.
Thoracic duct lymph (TDL) flow also increased, whereas thoracic duct lymph/serum (TDL/S) protein
decreased. These findings represent "stasis" or "passive congestion" of the portal system. *PRU = pe-
ripheral resistance units (arterial-mesenteric venous pressure) (mmHg)/SMA flow (ml/min). (Reprinted
with permission ofAnnals ofSurgery) (15)
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FIG. 3. Circulatory dynamics in the extrahepatic portal bed of the dog after induction of hyperdy-
namic mesenteric blood flow by systemic infusion of glucagon. Despite doubling of superior mesenteric
arterial (SMA) flow, portal pressure, mesenteric venous oxygen saturation (HbO2), and arterial-
mesenteric venous (A-MV) oxygen extraction were minimally altered. Mesenteric vascular resistance
decreased as SMA flow increased. There was also a modest increase in thoracic duct lymph (TDL)
formation and a slight fall in thoracic duct lymph/serum (TDL/S) protein ratio. *PRU = arterial-
mesenteric venous pressure (mmHg)/SMA flow (ml/min) (Reprinted with permission of Annals ofSur-
gery) (15).
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FIG. 4. Circulatory dynamics in the extrahepatic portal bed of the dog after induction of portal vein
constriction combined with systemic infusion ofglucagon. Superior mesenteric arterial (SMA) flow was
slightly increased and mesenteric vascular resistance lowered. Mesenteric venous oxygen saturation
(HbO2) remained high and arterial-mesenteric venous (A-MV) oxygen extraction unaltered. Thoracic
duct lymph (TDL) formation is similarly increased and thoracic duct lymph/serum (TDL/S) protein
content reduced. These findings represent "active congestion" in contrast to "passive congestion" ofthe
portal system (see Fig. 6). *PRU = arterial-mesenteric venous pressure (mmHg)/SMA flow (ml/min).
Reprinted with permission ofAnnals ofSurgery (15).PORTAL HYPERTENSION
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transhepatic portal flow and/or depression of reticuloendothelial activity in the liver
(30, 31). Thus, while the specific etiology may differ, the basic stimulus for
splenomegaly and hyperdynamic splenic blood flow-namely, reticuloendothelial
hyperplasia- is similar in diseases as diverse as hereditary spherocytosis and cir-
rhosis of the liver.
The critical role of the spleen in portal hypertension is well shown by hemody-
namic data before and after splenectomy in a middle-aged woman with hepatic cir-
rhosis, massive splenomegaly, and intractable ascites. This patient exhibited a
markedly hyperdynamic splenic circuit, rapid portal flow, and only minimally ele-
vated portal vascular resistance (Fig. 6). After ligation of a greatly enlarged splenic
artery (blood flow estimated at 1200 ml/min), portal pressure fell from 39 to 25 cm
saline. Despite increased resistance to transhepatic portal flow, the major factor
responsible for her severe portal hypertension was a massive influx of splenic blood
into the portal system. Splenectomy alone was performed and ascites has not
returned. Reexamination of portal dynamics 5 yr later revealed normal transhepatic
blood flow with only mild portal hypertension (Fig. 7). Similar splenic hemody-
namics in other patients with portal hypertension are shown in Figs. 8 and 9.
Muscle and skin are other sites ofhyperdynamic blood flow in patients with portal
hypertension from hepatic cirrhosis (36). The spider angioma, a common cutaneous
"stigma" of this disorder, consists of a plexus of dilated arterioles as nicely
illustrated by arteriography (Fig. 10) and comparative blood gases (Table 1). In
contrast to the splanchnic bed where hyperdynamic blood flow is met by increased
venous resistance through the cirrhotic liver, rapid flow in the skin (and elsewhere
outside the abdomen) does not ordinarily encounter increased venous resistance
and, therefore, regional venous hypertension does not develop.
Thus, while resistance to portal flow may be the sine qua non in the pathogenesis
of portal hypertension, the magnitude of portal pressure elevation and the varied
clinical sequelae that ensue probably reflect the broad spectrum of blood (and
lymph) circulatory dynamics in the splenic, mesenteric, portal, and hepatic systems
in this syndrome. In the care of patients with pulmonary hypertension, surgical
treatment often depends upon hemodynamic data acquired through cardiac
catheterization. For example, "high flow" pulmonary hypertension from patent
ductus arteriosus responds nicely to ligature of the ductus, whereas the same
operation with "high resistance" pulmonary hypertension may be catastrophic.
Similar considerations may indeed apply to the syndrome of portal hypertension.
Thus, when a hyperdynamic splenic circuit is the major factor generating portal
hypertension,4 splenectomy alone or splenic artery ligation without complete diver-
sion of the portal stream may be the preferable operation (38-40). On the other
hand, when high-resistance portal hypertension predominates, this particular ap-
proach may be ineffective or even hazardous and portasystemic shunt operations
may be necessary. It is suggested, therefore, that the hemodynamics of the
splanchnic bed be clarified in patients suffering from the complications of portal
hypertension particularly if standard drug therapy is unsatisfactory and operation is
contemplated.
4A close correlation exists between the size of the splenic artery on celiac angiography or at operation
and the rate of splenic blood flow (38, 41, 42). Our own estimated formula is a flow rate of 100 ml/min/
mm of splenic artery diameter. A diameter of >8 mm signifies that splenic blood flow contributes to
portal hypertension (21).
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FIG. 6. Splenoportography (A) and celiac angiography (B) (reprinted with permission of J. Amer.
Med. Assoc.) (32) in a 41-yr-old woman with posthepatitic cirrhosis and massive ascites. Hemodynamic
findings indicated a hyperdynamic splenic circulation with slightly increased postsinusoidal hepatic re-
sistance to portal flow. Splenic arterial flow was 1.2 liters/min and hepatic arterial flow was 670 ml/min
(measured at laparotomy with a noncannulating electromagnetic flowmeter). Total liver blood flow was
2270 ml/min (indocyanine green extraction) and calculated portal flow was 1.6 liters/min. Portal
vascular resistance was slightly increased (hepatic wedge pressure-free hepatic vein pressure = 44-16 cm
saline). After splenectomy portal pressure fell from 38 to 25 cm saline (see Fig. 3).
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FIG. 7. Venous phase of a superior mesenteric arteriogram in a 41-yr-old woman 5 yr after sple-
nectomy for treatment of ascites secondary to hepatic cirrhosis and portal hypertension. Estimated he-
patic blood flow (indocyanine green extraction) which before splenectomy was 2270 ml/min was now
1350 ml/min. Hepatic wedge pressure-free hepatic vein pressure was now 21-15 cm saline (see Fig. 6).
(Reprinted with permission ofJ. Amer. Med. Assoc.) (33).
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FIG. 8. Selective splenic arteriogram (top) in a middle-aged woman with polycythemia vera, massive
splenomegaly, ascites, and varix hemorrhage. Venous phase (outlined) demonstrates huge, tortuous
splenic and portal vein (bottom). Spleen (inset) weighed over 3 kg and splenic arterial flow was 1500 ml/
min (noncannulating electromagnetic flowmeter). Splenectomy lowered portal pressure from 28 to 20
mmHg. Although the patient's disease has progressed to myelogenous leukemia, she is free ofascites and
esophageal varix hemorrhage. (Reprinted with permission ofMarcel Dekker, Inc.) (34).
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FIG. 9. Selective splenic arteriography in a frail 59-yr-old woman with postnecrotic cirrhosis, marked
splenomegaly, severe thrombocytopenia with easy bruisability, and epistaxis. Note theenlarged, tortuous
splenic artery (A) and huge splenic vein that drains via a large coronary vein into prominent esophageal
varices (B). At laparotomy splenic arterial flow was 850 ml/min (noncannulating electromagnetic
flowmeter), and splenectomy lowered portal pressure from 28 to 22 cm saline. (Reprinted with per-
mission ofAnn. Surg.) (35).
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FIG. 10. Subclavian arteriogram of a large spider angioma of the arm in a patient with hepatic cir-
rhosis. Note the single arteriole "feeding" into a racemose vascular network (A) with prompt drainage
via a solitary venous tributary (arrow) into the basilic vein (B). (Reprinted with permission of South.
Med. J.) (37).
TABLE 1
Respiratory Gas Tensions and pH in Blood Aspirated from the Radial Artery,
Basilic Vein and a Vascular Spider in a Patient with Hepatic Cirrhosis
PG2 PC02
(mmHg) (mmHg) pH
Vascular spider 63 33 7.42
Radial artery 63 33 7.42
Basilic vein 38 36 7.37
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